0001415889-21-002957.txt : 20210611 0001415889-21-002957.hdr.sgml : 20210611 20210611163007 ACCESSION NUMBER: 0001415889-21-002957 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210610 FILED AS OF DATE: 20210611 DATE AS OF CHANGE: 20210611 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Horn Kinney CENTRAL INDEX KEY: 0001831215 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39712 FILM NUMBER: 211011662 MAIL ADDRESS: STREET 1: C/O OLEMA PHARMACEUTICALS, INC. STREET 2: 512 2ND STREET, 4TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Olema Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001750284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 300409740 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 512 2ND STREET, 4TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94107 BUSINESS PHONE: (415) 651-3316 MAIL ADDRESS: STREET 1: 512 2ND STREET, 4TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94107 4 1 form4-06112021_010653.xml X0306 4 2021-06-10 0001750284 Olema Pharmaceuticals, Inc. OLMA 0001831215 Horn Kinney C/O OLEMA PHARMACEUTICALS, INC. 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 false true false false CHIEF BUSINESS OFFICER Common Stock 2021-06-10 4 M 0 5251 2.064 A 7041 D Common Stock 2021-06-10 4 S 0 300 28.30 D 6741 D Common Stock 2021-06-10 4 S 0 2164 29.60 D 4577 D Common Stock 2021-06-10 4 S 0 2787 29.97 D 1790 D Stock Option (right to buy) 2.064 2021-06-10 4 M 0 5251 0 D 2030-06-09 Common Stock 5251 189046 D The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. The weighted average sale price for the transaction reported was $28.30, and the range of prices were between $27.79 and $28.63. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. The weighted average sale price for the transaction reported was $29.60, and the range of prices were between $28.81 and $29.80. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. The weighted average sale price for the transaction reported was $29.97, and the range of prices were between $29.82 and $30.21. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. The shares subject to the option vest in a series of 48 successive equal monthly installments measured from June 10, 2020, subject to the Reporting Person's continuous service through each applicable vesting date. /s/ John B. Moriarty, Jr., Attorney-in-Fact 2021-06-11